Literature DB >> 8485655

Quality of life in cancer: definition, purpose, and method of measurement.

D F Cella1, D S Tulsky.   

Abstract

Over the past 20 years, changes within medicine and society have encouraged an expansion in conceptualizing and evaluating the goals and important outcomes of medical treatments. In evaluating the care of people with cancer and other chronic illnesses, a major part of the expansion has been the inclusion of means to assess the quality of life in addition to the quantity of life associated with various treatments. This paper presents a review of the current literature on quality-of-life assessment in oncology research and practice. The review is organized around current thinking about the definition of quality of life, the purpose of quality-of-life measurement, the method of assessment, and the competing advantages and disadvantages of disease-specific versus general health outcome measurement. Recommendations for proceeding with quality-of-life measurement in oncology are provided to encourage increased attention to the need to remain closely tied to a theoretical construct.

Entities:  

Mesh:

Year:  1993        PMID: 8485655     DOI: 10.3109/07357909309024860

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  70 in total

Review 1.  Operational aspects of Quality-of-Life Assessment. Choosing the right instrument.

Authors:  P Erickson; R C Taeuber; J Scott
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

2.  Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia.

Authors:  Ricardo Sánchez; Monica Ballesteros; Benjamin J Arnold
Journal:  Qual Life Res       Date:  2010-10-30       Impact factor: 4.147

3.  Working Toward Normalcy Post-Treatment: A Qualitative Study of Older Adult Breast and Prostate Cancer Survivors.

Authors:  Rachel Walker; Sarah L Szanton; Jennifer Wenzel
Journal:  Oncol Nurs Forum       Date:  2015-11       Impact factor: 2.172

4.  Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma.

Authors:  Kimlin T Ashing-Giwa; Judith S Tejero; Jinsook Kim; Geraldine V Padilla; Gerhard Hellemann
Journal:  Qual Life Res       Date:  2007-02-06       Impact factor: 4.147

Review 5.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

6.  Self-perception versus professional assessment of functional outcome after ablative surgery in patients with oral cancer.

Authors:  Benedicta E Beck-Broichsitter; Jörn Huck; Thomas Küchler; Daniela Hauke; Jürgen Hedderich; Jörg Wiltfang; Stephan T Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

7.  Utilizing Multidimensional Computer Adaptive Testing to Mitigate Burden With Patient Reported Outcomes.

Authors:  Michael Bass; Scott Morris; Richard Neapolitan
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

8.  How oncologists and their patients with advanced cancer communicate about health-related quality of life.

Authors:  Keri L Rodriguez; Nichole Bayliss; Stewart C Alexander; Amy S Jeffreys; Maren K Olsen; Kathryn I Pollak; Sarah L Kennifer; James A Tulsky; Robert M Arnold
Journal:  Psychooncology       Date:  2010-05       Impact factor: 3.894

Review 9.  Prostate cancer and health-related quality of life: a review of the literature.

Authors:  David T Eton; Stephen J Lepore
Journal:  Psychooncology       Date:  2002 Jul-Aug       Impact factor: 3.894

10.  A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.

Authors:  Youssef A Rezk; Karen E Hurley; Jeanne Carter; Fanny Dao; Bernard H Bochner; Janice J Aubey; Aileen Caceres; M Heather Einstein; Nadeem R Abu-Rustum; Richard R Barakat; Vicky Makker; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2012-10-09       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.